A NEW programme to bring a novel microfluidic DNA-based testing and diagnostics technology to point-of-care settings has been launched by a consortium of LingVitae, Plarion, and KTH Royal Institute of Technology. The technology, called Discipher, exploits ‘centrifugal microfluidics’. Based on…